SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Spectral Medical Inc.
An SI Board Since October 2011
Posts SubjectMarks Bans Symbol
522 11 0 EDTXF
Emcee:  Sultan Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
522TIGRIS and EUPHRATES eventually join and provide new evidence: a narrative revieSultan-January 14
521Effects on mortality of blood purification techniques in severe septic shock patSultan-12/31/2025
520The topline results from the Tigris trial mark an important step forward in advaSultan-10/13/2025
519Join the Sepsis Alliance Institute for an in-depth exploration of the TIGRIS triSultan-10/9/2025
518Looks like Vantive is going full speed ahead to be ready to launch if and when FSultan-10/3/2025
517Spectral Medical Announces Publication of EDEN Observational Study New Study StSultan-9/16/2025
516A new publication in Critical Care Explorations highlights the critical relationSultan-9/9/2025
515youtube.comSultan-9/9/2025
514 Canada must put together plan to tackle sepsis, researchers warn By Adrian GhSultan-9/9/2025
513 Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, Sultan-9/8/2025
512 Spectral Medical is a stock to buy now, this analyst says Paradigm Capital anaSultan-8/27/2025
511TIGRIS Unlocked: Evidence to Impact Sepsis Alliance gratefully acknowledges theSultan-8/26/2025
510 Spectral Medical Receives US$3 Million From Vantive TORONTO, Aug. 25, 2025Sultan-8/25/2025
509Announcement of Spectral Medical’s Tigris Trial Topline Results for “TORAYMYXIN™Sultan-8/21/2025
508If you have been following Spectral Medical Inc. Phase III Trial Results on SepsSultan-8/18/2025
507Tigris Trial Topline Results Call Replay August 13, 2025 spectraldx.comSultan-8/13/2025
506Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris TriSultan-8/12/2025
505Spectral Medical Announces Second Quarter and Provides Corporate Update financeSultan-8/8/2025
504Vantive’s Transformative Impact on Renal Care Vantive has the unique distinctioSultan-6/26/2025
503Overview This agreement outlines the terms between Spectral Medical Inc. and VaSultan-5/23/2025
502Spectral Medical Update as posted on Linkedin Today We’re pleased to share impoSultan-5/13/2025
501Spectral Medical is “fundamentally undervalued”, Paradigm says [graphic] ParadiSultan-5/8/2025
500Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with VantSultan-5/7/2025
499The Tigris Trial and Corporate Update Call Join Chris Seto, Chief Executive OffSultan-5/6/2025
498The TIGRIS Trial is a confirmatory study of Toraymyxin™ PMX Hemoperfusion in addSultan-4/28/2025
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News